CAREDX, INC. Operating Lease, Payments
CAREDX, INC. (CDNA) reported Operating Lease, Payments of $1.57 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-07-30
- CAREDX, INC. operating lease, payments for the quarter ending 2026-06-30 was $1.57M, a 5.66% increase year-over-year.
- CAREDX, INC. operating lease, payments for the quarter ending 2026-03-31 was $1.55M, a 3.95% increase year-over-year.
- CAREDX, INC. operating lease, payments for the quarter ending 2025-12-31 was $1.56M, a 65.32% increase year-over-year.
- CAREDX, INC. operating lease, payments for the quarter ending 2025-09-30 was $1.52M, a 3.13% decline year-over-year.
- CAREDX, INC. operating lease, payments for fiscal 2025 was $6.05M, a 13.41% increase from fiscal 2024.
- CAREDX, INC. operating lease, payments for fiscal 2024 was $5.34M, a 2.11% decline from fiscal 2023.
- CAREDX, INC. operating lease, payments for fiscal 2023 was $5.45M, a 48.81% increase from fiscal 2022.
- CAREDX, INC. operating lease, payments for fiscal 2022 was $3.67M, a 42.05% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.57M 10-Q · filed 2026-07-30 | $3.12M 10-Q · filed 2026-07-30 | $4.68M derived: sum of 3 quarters · filed 2026-07-30 | $6.20M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $1.55M 10-Q · filed 2026-04-28 | $3.11M derived: sum of 2 quarters · filed 2026-04-28 | $4.63M derived: sum of 3 quarters · filed 2026-04-28 | $6.11M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $3.08M derived: sum of 2 quarters · filed 2026-02-25 | $4.56M derived: sum of 3 quarters · filed 2026-07-30 | $6.05M 10-K · filed 2026-02-25 |
| 2025-09-30 | $1.52M 10-Q · filed 2025-11-04 | $3.00M derived: sum of 2 quarters · filed 2026-07-30 | $4.50M 10-Q · filed 2025-11-04 | $5.44M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $1.48M 10-Q · filed 2026-07-30 | $2.98M 10-Q · filed 2026-07-30 | $3.92M derived: sum of 3 quarters · filed 2026-07-30 | $5.49M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $1.49M 10-Q · filed 2026-04-28 | $2.44M derived: sum of 2 quarters · filed 2026-04-28 | $4.00M derived: sum of 3 quarters · filed 2026-04-28 | $5.47M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $943.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.51M derived: sum of 2 quarters · filed 2026-02-25 | $3.98M derived: sum of 3 quarters · filed 2026-02-25 | $5.34M 10-K · filed 2026-02-25 |
| 2024-09-30 | $1.57M 10-Q · filed 2025-11-04 | $3.04M derived: sum of 2 quarters · filed 2025-11-04 | $4.40M 10-Q · filed 2025-11-04 | $5.98M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $1.47M 10-Q · filed 2025-08-06 | $2.83M 10-Q · filed 2025-08-06 | $4.41M derived: sum of 3 quarters · filed 2026-02-25 | $5.58M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $1.36M 10-Q · filed 2025-04-30 | $2.94M derived: sum of 2 quarters · filed 2026-02-25 | $4.12M derived: sum of 3 quarters · filed 2026-02-25 | $5.48M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.75M derived: sum of 2 quarters · filed 2026-02-25 | $4.12M derived: sum of 3 quarters · filed 2026-02-25 | $5.45M 10-K · filed 2026-02-25 |
| 2023-09-30 | $1.17M 10-Q · filed 2024-11-04 | $2.54M derived: sum of 2 quarters · filed 2024-11-04 | $3.87M 10-Q · filed 2024-11-04 | $4.79M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $1.37M 10-Q · filed 2024-07-31 | $2.70M 10-Q · filed 2024-07-31 | $3.62M derived: sum of 3 quarters · filed 2025-02-28 | $4.44M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $1.33M 10-Q · filed 2024-05-09 | $2.25M derived: sum of 2 quarters · filed 2025-02-28 | $3.07M derived: sum of 3 quarters · filed 2025-02-28 | $4.03M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $919.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $1.74M derived: sum of 2 quarters · filed 2025-02-28 | $2.69M derived: sum of 3 quarters · filed 2025-02-28 | $3.67M 10-K · filed 2025-02-28 |
| 2022-09-30 | $822.00K 10-Q · filed 2023-11-08 | $1.77M derived: sum of 2 quarters · filed 2023-11-08 | $2.75M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $952.00K 10-Q · filed 2023-08-08 | $1.92M 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $972.00K 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | $2.58M 10-K · filed 2024-02-28 | |||
| 2020-12-31 | $934.00K 10-K · filed 2023-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |